[
  {
    "ts": null,
    "headline": "Piper Sandler Cuts Price Target on Constellation Brands (STZ) as it Faces Headwinds From GLP-1 Weight Loss Drugs",
    "summary": "Constellation Brands, Inc. (NYSE:STZ) ranks among the best sin stocks to buy in 2026. On November 21, Piper Sandler cut its price target for Constellation Brands, Inc. (NYSE:STZ) to $135 from $155 while keeping a Neutral rating for the alcohol company. The firm cited increasing strain from GLP-1 weight loss pharmaceuticals as a major reason […]",
    "url": "https://finnhub.io/api/news?id=828633f346fd85655e1a12aa19d8f1c82c766ea05562e5d63db8a6c1a16cf866",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765773881,
      "headline": "Piper Sandler Cuts Price Target on Constellation Brands (STZ) as it Faces Headwinds From GLP-1 Weight Loss Drugs",
      "id": 137793196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STZ",
      "source": "Yahoo",
      "summary": "Constellation Brands, Inc. (NYSE:STZ) ranks among the best sin stocks to buy in 2026. On November 21, Piper Sandler cut its price target for Constellation Brands, Inc. (NYSE:STZ) to $135 from $155 while keeping a Neutral rating for the alcohol company. The firm cited increasing strain from GLP-1 weight loss pharmaceuticals as a major reason […]",
      "url": "https://finnhub.io/api/news?id=828633f346fd85655e1a12aa19d8f1c82c766ea05562e5d63db8a6c1a16cf866"
    }
  }
]